增强现实用于患者和其他重大中风教育:可行性研究
Emma Finch1,2,3, Ellie Minchell1, Ashley Cameron2,4
1School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia.
概括
增强现实 (AR) 课程可用于改善中风患者及其家属的教育. 这项技术有望提高中风知识和信心,使教育更容易获得.
科学领域:
- 神经学 神经学
- 医疗教育 技术 技术 医学教育
- 数字健康数字健康
背景情况:
- 全球中风教育率较低会增加二次中风风险.
- 技术提供解决方案,以提高中风教育的可访问性.
- 增强现实 (AR) 是提高中风患者教育的潜在工具.
研究的目的:
- 开发和试验一个增强现实 (AR) 中风教育课程.
- 评估使用AR用于中风患者教育的可行性.
- 收集关于参与者经验和知识改进的见解.
主要方法:
- 采用了一种可行性研究设计.
- 19名中风患者和3名重要患者参与了这项试验.
- 参与者与基于平板电脑的AR应用程序进行互动,其中包括讲述的音频课程和模型大脑.
主要成果:
- 实现了高招聘率 (58%) 和保留率 (100%).
- 90%的参与者使用了课程,大多数人独立使用 (81.82%).
- 超过80%的人对乐趣,实用性和学习表示积极的看法,72.73%的人对中风知识的信心增加.
结论:
- 增强现实 (AR) 是为患者及其支持网络提供技术增强中风教育的可行方法.
- 这项研究表明,AR有可能提高中风知识和信心.
- 为了更广泛的实施,建议进行进一步的研究和课程改进.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...


